Covered recipient · General Payments record
NANDAN BHATT
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2019–2025
$2,871.24
- Reported across 196 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $428.48 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $253.57 | 11 |
| E.R. Squibb & Sons, L.L.C. | $99.27 | 4 |
| Teva Pharmaceuticals USA, Inc. | $54.12 | 2 |
| ABBVIE INC. | $21.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.52 | 01/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201515244 | CMS |
| Alkermes, Inc. | $29.46 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447533 | CMS |
| Alkermes, Inc. | $1.96 | 01/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447535 | CMS |
| Alkermes, Inc. | $32.26 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447537 | CMS |
| Alkermes, Inc. | $28.99 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447539 | CMS |
| Alkermes, Inc. | $2.69 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447541 | CMS |
| Alkermes, Inc. | $34.18 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447543 | CMS |
| Alkermes, Inc. | $31.09 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447545 | CMS |
| Alkermes, Inc. | $34.37 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447547 | CMS |
| Alkermes, Inc. | $24.10 | 06/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447549 | CMS |
| Alkermes, Inc. | $2.99 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447551 | CMS |
| Alkermes, Inc. | $31.48 | 08/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222447553 | CMS |
| E.R. Squibb & Sons, L.L.C. | $38.25 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184849716 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.83 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184849724 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.61 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184849768 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.58 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184849788 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.05 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247369741 | CMS |
| Teva Pharmaceuticals USA, Inc. | $33.07 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247369823 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.